During this unique period, clients of Reveal Biosciences are able to request quotes and upload digital images for quantitative analysis. To support efforts to contain the spread of COVID-19 and in compliance with California’s stay-at-home order, Reveal will temporarily suspend certain lab operations, such as tissue processing and slide preparation.
ARTIFICIAL INTELLIGENCE IS REVOLUTIONIZING PATHOLOGY
Advanced pathology for preclinical research, clinical trials, and decision support
Advancing Research, Improving Patient Outcomes
Take advantage of our high quality histopathology research services to generate quantitative pathology end points.
Access the the most advanced AI-powered digital assay pathology platform in the cloud.
Clinical Decision Support
Incorporate AI-powered pathology decision support tools to improve patient outcomes.
Pathology Powered By
High quality immunohistochemistry (IHC) combined with whole slide imaging and cell-by-cell quantification to advance your research.
Access the most advanced quantitative NASH and fibrosis data from your human or rodent liver samples.
Data powered pathology for advanced research & better patient care
Latest research, in the news, or at events.
Research into developing effective treatments for non-alcoholic steatohepatitis (NASH) is becoming more important as the incidence of NASH increases in the general population. Mouse and rat models are used
The staggering cost of healthcare in America continues to rise, especially for wound healing. In 2014, wound-related healthcare expenses for Medicare beneficiaries were conservatively estimated at $28.1 billion, with
Precision medicine has come a long way towards benefiting patient outcomes and enhancing research tools. In recent years, the integration of multi-scale omics from genomic, proteomic, and transcriptomic foundations